A Multicentre study of anticoagulation in operable chronic thromboembolic pulmonary hypertension.

Katherine Bunclark, Michael Newnham, Yi-Da Chiu, Alessandro Ruggiero, Sofia S Villar, John E Cannon, Gerry Coghlan, Paul A Corris, Luke Howard, David Jenkins, Martin Johnson, David G Kiely, Choo Ng, Nicholas Screaton, Karen Sheares, Dolores Taboada, Steven Tsui, John S Wort, Joanna Pepke-Zaba & Mark Toshner
Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon complication of acute pulmonary emboli necessitating lifelong anticoagulation. Despite this, little data exists on the safety and efficacy of Vitamin K Antagonists (VKAs) in CTEPH and none for Direct Oral Anticoagulants (DOACs). To evaluate outcomes and complication rates in CTEPH following Pulmonary Endarterectomy (PEA) for individuals receiving VKAs or DOACs. Consecutive CTEPH patients undergoing PEA between 2007 and 2018 were included in a retrospective analysis. Post-operative outcomes,...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.